Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J M Hesselink

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Idrugs : the Investigational Drugs Journal|August 30, 2005
Iloperidone (Hoechst Marion Roussel Inc)J M Hesselink
Acta Neuropsychiatrica|March 10, 2016
Clinical evaluation of antidepressant drugs; Guidelines from authoritiesJ M Hesselink
Acta Neuropsychiatrica|March 12, 2016
Pharmacotherapeutical treatment of personality disordersJ M Hesselink
Progress in Neuro-Psychopharmacology & Biological Psychiatry|May 1, 1994
A phase II multicenter dose-finding, efficacy and safety trial of ipsapirone in outpatients with generalized anxiety disorderN R Cutler, J M Hesselink, J J Sramek
The International Journal of Eating Disorders|May 1, 1995
Ipsapirone in the treatment of bulimia nervosa: an open pilot studyC Geretsegger, K V Greimel, I S Roed, et al.
European Journal of Clinical Pharmacology|January 1, 1991
Nimodipine tested in a human model of cerebral ischaemia. Electroencephalographic and transcranial Doppler ultrasound investigations in normal subjects during standardized hyperventilationV Kraaier, A C van Huffelen, G H Wieneke, et al.
The Journal of International Medical Research|September 1, 1996
The effect of nimodipine monotherapy and combined treatment with ketamine and lignocaine in aneurysmal subarachnoid haemorrhageG Langelaar, O R Leeuwenkamp, L G Sterkman, et al.
Psychopharmacology Bulletin|January 1, 1993
The safety and efficacy of ipsapirone vs. lorazepam in outpatients with generalized anxiety disorder (GAD): single site findings from a multicenter trialN R Cutler, J J Sramek, T S Wardle, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Idrugs : the Investigational Drugs Journal|August 30, 2005
Iloperidone (Hoechst Marion Roussel Inc)J M Hesselink
Acta Neuropsychiatrica|March 10, 2016
Clinical evaluation of antidepressant drugs; Guidelines from authoritiesJ M Hesselink
Acta Neuropsychiatrica|March 12, 2016
Pharmacotherapeutical treatment of personality disordersJ M Hesselink
Progress in Neuro-Psychopharmacology & Biological Psychiatry|May 1, 1994
A phase II multicenter dose-finding, efficacy and safety trial of ipsapirone in outpatients with generalized anxiety disorderN R Cutler, J M Hesselink, J J Sramek
The International Journal of Eating Disorders|May 1, 1995
Ipsapirone in the treatment of bulimia nervosa: an open pilot studyC Geretsegger, K V Greimel, I S Roed, et al.
European Journal of Clinical Pharmacology|January 1, 1991
Nimodipine tested in a human model of cerebral ischaemia. Electroencephalographic and transcranial Doppler ultrasound investigations in normal subjects during standardized hyperventilationV Kraaier, A C van Huffelen, G H Wieneke, et al.
The Journal of International Medical Research|September 1, 1996
The effect of nimodipine monotherapy and combined treatment with ketamine and lignocaine in aneurysmal subarachnoid haemorrhageG Langelaar, O R Leeuwenkamp, L G Sterkman, et al.
Psychopharmacology Bulletin|January 1, 1993
The safety and efficacy of ipsapirone vs. lorazepam in outpatients with generalized anxiety disorder (GAD): single site findings from a multicenter trialN R Cutler, J J Sramek, T S Wardle, et al.
Pageof 1